News2021-10-14T10:21:56+00:00

FEATURED NEWS

QP Declarations – Key Considerations

So are you preparing and filing a Marketing Authorisation Application (MAA) in Europe? What needs to be considered and what timelines

MHRA (GxP) Inspections during COVID19

October 12th, 2020|

The COVID19 pandemic presents an unprecedented challenge to healthcare, the pharmaceutical industry’s supply chain and personnel movement. MHRA understands the impact of its work

LET US HELP YOU DELIVER YOU PRODUCTS TO MARKET

Interested in our services or still have a question?

Go to Top